Skip to content

ANEUROTECH

Active Private limited companyfounded 2022active for 4 yearsAlkerstraat 30 A, 3570 AlkenKBO/BCE: BE 0785.263.993 #10 company by total assets in Limburg, Research and development sector

Board

1 director, 1 in day-to-day management, last change in December 2022
Director
since 09-11-2022 term without a fixed end
listed in the 2025 annual accounts, filed on 31-08-2026
Managing director, permanent representative Erik Buntinx
appointed by deed of 29-07-2022
also on the board of 2 other companies
Day-to-day management
EB Pharma Developments
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Artikel 24 van de statuten van de Vennootschap dat de vertegenwoordiging van de Vennootschap regelt, luidt als volgt: "(...) Indien meerdere…”
deed of 12-12-2022
Permanent representatives 1
Erik Buntinx
Permanent representative, for EB Pharma Developments
appointed by deed of 29-07-2022

Office holders in the KBO →

Mandates through the years

4 names, the dashed line is today
Rudi Pauwels
Director
EB Pharma Developments
Managing director
Arkenstone Investments S.L.
Director
Patinir LLC
Director
LeadershipBoardEarliermandate already running before its first mentionend not dated
Mandates as a list
  • Rudi Pauwels
    • Director, from 09-11-2022 to date
  • EB Pharma Developments
    • Managing director, from 14-04-2022 to date
  • Arkenstone Investments S.L.
    • Director, appointed by deed of 29-07-2022, until 12-12-2022
  • Patinir LLC
    • Director, until 29-08-2022
    • Director, appointed by deed of 29-09-2022, no longer listed in the 2025 annual accounts

Control

Subscribers
KOIS HOLDINGS SOCIETE CIVILE DE DROIT COMMUN, Jelte Andries
This company
ANEUROTECH
Equity €610,913
Loss €701,586 in 2025

Capital

Contribution
€2,085,358.34
Shares
10,616 in the deed of 26-07-2023 and 3 later capital increases
Contribution per share
€196
Equity per share
€57.55 in 2025
Source
2025 annual accounts

Articles of association

Board ruleThese rules set how the board is made up, meets and takes decisions.
At least 2 directors
“Bepaald door algemene vergadering die benoemt, met of zonder beperking van duur, raad van bestuur”
deed of 07-09-2023 (in Dutch)
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
“aandeelhouders naar verhouding van het aantal aandelen dat zij bezitten en worden de goederen die nog in natura voorhanden zijn op dezelfde…”
deed of 10-02-2023 (in Dutch)

Shareholders

After 2 capital increases deed of 08-03-2024 ↗
After the capital increase deed of 07-09-2023 ↗
  • BEUKEMA Reinder Klaas 57 shares · €150,195 · “overschrijving op bijzondere rekening op naam vennootschap”

Capital transactions

Capital over time
  1. 08-03-2024 Capital increase of €231,395.89 · 88 new shares
  2. 08-03-2024 Capital increase of €400,520 · 152 new shares
  3. 07-09-2023 Capital increase of €150,195 · 57 new shares
  4. 26-07-2023 Capital stated in the deed · 10,319 shares
  5. 10-02-2023 Capital stated in the deed · 9,750 shares

Next steps